Guest editorial: Medical bionics: from emerging technologies to clinical practice

There have been many bionic devices approved for clinical use; the modern neurotechnology industry is dominated by five major commercial applications including: (i) auditory prostheses that provide auditory cues for severe and profoundly deaf; (ii) spinal cord stimulation (SCS) for treatment of chro...

Full description

Saved in:
Bibliographic Details
Published in:Healthcare technology letters 2020-06, Vol.7 (3), p.51-51
Main Author: Shepherd, Robert K
Format: Article
Language:English
Subjects:
Control algorithms
Parkinson's disease
Prostheses
Special Issue: Medical Bionics: From Emerging Technologies to Clinical Practice
Spinal cord injuries
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There have been many bionic devices approved for clinical use; the modern neurotechnology industry is dominated by five major commercial applications including: (i) auditory prostheses that provide auditory cues for severe and profoundly deaf; (ii) spinal cord stimulation (SCS) for treatment of chronic back pain; (iii) vagal nerve stimulation for the control of epilepsy and treatment of depression; (iv) deep brain stimulation (DBS) for motor control in Parkinson's disease (PD) and essential tremor, and (v) sacral root stimulation for improved bladder and bowel function. Parker, Karantonis and Single describe the closed-loop control of SCSs used to maintain a predetermined level of neural recruitment, and propose a hypothesis to explain the difference in efficacy between open-and closed-loop operational modes. [...]Parker and Dietz report on the potential application of SCS to reduce spasticity associated with cerebral palsy.
ISSN:2053-3713
2053-3713
DOI:10.1049/htl.2020.0047